This Dow Jones headline alone would send seismic tremors in the CV world!!
Its worth noting that from Novartis' perspective, paraphrasing @The Yankee...
Think about how perfectly Entresto would complement MESO's Revascor. This would make for a perfect end-to-end treatment in heart disease. Now throw in their recent purchase of the LDL-C reducing drug Inclisiran and you have just found your "one stop shop " in an incredibly powerful combination treatment for the number one killer in the world - heart disease.
If I were Novartis, I would be revising my cheque for the upfront payment and terms of the partnership to now include Revascor in the mix.
- Forums
- ASX - By Stock
- MSB
- Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF, page-112
-
-
- There are more pages in this discussion • 652 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.050B |
Open | High | Low | Value | Volume |
92.0¢ | 92.5¢ | 91.5¢ | $1.133M | 1.233M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 151980 | 91.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
92.0¢ | 29989 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 151980 | 0.915 |
17 | 171695 | 0.910 |
10 | 114726 | 0.905 |
41 | 340538 | 0.900 |
5 | 98985 | 0.895 |
Price($) | Vol. | No. |
---|---|---|
0.920 | 29989 | 2 |
0.925 | 87769 | 6 |
0.930 | 71346 | 6 |
0.935 | 64930 | 3 |
0.940 | 14060 | 3 |
Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |